Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
Copyright © 2018 Massachusetts Medical Society. BACKGROUND Pregnant women with an elevated viral load of hepatitis B virus (HBV) have a risk of transmitting infection to their infants, despite the infants' receiving hepatitis B immune globulin. METHODS In this multicenter, double-blind clinical...
Saved in:
Main Authors: | G. Jourdain, N. Ngo-Giang-Huong, L. Harrison, L. Decker, W. Khamduang, C. Tierney, N. Salvadori, T. R. Cressey, W. Sirirungsi, J. Achalapong, P. Yuthavisuthi, P. Kanjanavikai, O. P. Na Ayudhaya, T. Siriwachirachai, S. Prommas, P. Sabsanong, A. Limtrakul, S. Varadisai, C. Putiyanun, P. Suriyachai, P. Liampongsabuddhi, S. Sangsawang, W. Matanasarawut, S. Buranabanjasatean, P. Puernngooluerm, C. Bowonwatanuwong, T. Puthanakit, V. Klinbuayaem, S. Thongsawat, S. Thanprasertsuk, G. K. Siberry, D. H. Watts, N. Chakhtoura, T. V. Murphy, N. P. Nelson, R. T. Chung, S. Pol, N. Chotivanich |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85043605260&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/58962 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
Similar Items
-
Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
by: G. Jourdain, et al.
Published: (2018) -
Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
by: Gonzague Jourdain, et al.
Published: (2018) -
Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
by: Tim R. Cressey, et al.
Published: (2018) -
Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
by: Cressey T., et al.
Published: (2017) -
Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
by: Jourdain G., et al.
Published: (2017)